Emanuel F. Petricoin

发表

Virtual reality and augmented reality: Advances in surgery

David B. Douglas, Clifford A Wilke, David Gibson, 2017 .

Nonlinear mixed effects dose response modeling in high throughput drug screens: application to melanoma cell line analysis

Jeffrey M. Trent, Darren Finlay, Kristiina Vuori, 2018, Oncotarget.

FINDbase: a worldwide database for genetic variation allele frequencies updated

Vassiliki Gkantouna, Giannis Tzimas, Konstantinos Poulas, 2011, Nucleic Acids Res..

Novel Approaches to Visualization and Data Mining Reveals Diagnostic Information in the Low Amplitude Region of Serum Mass Spectra from Ovarian Cancer Patients

Stanimire Tomov, Emanuel F. Petricoin, Donald J. Johann, 2004, Disease markers.

The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma

Emanuel F. Petricoin, Hong-Bin Fang, Sivanesan Dakshanamurthy, 2017, Oncotarget.

2D Differential In-gel Electrophoresis for the Identification of Esophageal Scans Cell Cancer-specific Protein Markers*

Nan Hu, Emanuel F. Petricoin, Michael R. Emmert-Buck, 2002, Molecular & Cellular Proteomics.

Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation.

Weidong Zhou, Alessandra Tessitore, Emanuel F. Petricoin, 2008, Nano letters.

Use of Reverse Phase Protein Microarrays and Reference Standard Development for Molecular Network Analysis of Metastatic Ovarian Carcinoma*

Yiling Lu, Emanuel F. Petricoin, Virginia Espina, 2005, Molecular & Cellular Proteomics.

High-resolution serum proteomic features for ovarian cancer detection.

Emanuel F. Petricoin, Donald J. Johann, Timothy D. Veenstra, 2004 .

Biomarker Amplification by Serum Carrier Protein Binding

Emanuel F. Petricoin, Mark S. Lowenthal, David A. Fishman, 2004, Disease markers.

Augmented Reality and Virtual Reality: Initial Successes in Diagnostic Radiology

David B. Douglas, Clifford A Wilke, Emanuel F. Petricoin, 2018 .

Clinical Applications of Proteomics: Proteomic Pattern Diagnostics

Emanuel F. Petricoin, Lance A. Liotta, E. Petricoin, 2002, Journal of Mammary Gland Biology and Neoplasia.

Serum Proteomic Analysis Identifies a Highly Sensitive and Specific Discriminatory Pattern in Stage 1 Breast Cancer

Emanuel F. Petricoin, Francesco Facchiano, Lance A. Liotta, 2007, Annals of Surgical Oncology.

Medical applications of microarray technologies: a regulatory science perspective

Emanuel F. Petricoin, Janet Woodcock, Kathryn C. Zoon, 2002, Nature Genetics.

Core-Shell Hydrogel Particles Harvest, Concentrate and Preserve Labile Low Abundance Biomarkers

Weidong Zhou, Emanuel F. Petricoin, Giovanni Pellacani, 2009, PloS one.

Multifunctional Core–Shell Nanoparticles: Discovery of Previously Invisible Biomarkers

Weidong Zhou, Emanuel F. Petricoin, Virginia Espina, 2011, Journal of the American Chemical Society.

Using Decision Forest to Classify Prostate Cancer Samples on the Basis of SELDI-TOF MS Data: Assessing Chance Correlation and Prediction Confidence

Weida Tong, Qian Xie, Huixiao Hong, 2004, Environmental health perspectives.

Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas

Emanuel F. Petricoin, Mark R. Conaway, Brian Capaldo, 2016 .

APPLICATION OF LASER CAPTURE MICRODISSECTION AND PROTEIN MICROARRAY TECHNOLOGIES IN THE MOLECULAR ANALYSIS OF AIRWAY INJURY FOLLOWING POLLUTION PARTICLE EXPOSURE

Emanuel F. Petricoin, Virginia Espina, Kevin L. Dreher, 2004, Journal of toxicology and environmental health. Part A.

Laser Capture Microdissection and Protein Microarray Analysis of Human Non-small Cell Lung Cancer

Emanuel F. Petricoin, Curtis C. Harris, Virginia Espina, 2008, Molecular & Cellular Proteomics.

Network-targeted combination therapy : a new concept in cancer treatment

Emanuel F. Petricoin, Robyn P. Araujo, Lance A. Liotta, 2004 .